Results 131 to 140 of about 29,458 (191)

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil. [PDF]

Open Forum Infect Dis
Stohs EJ, Alexander BT, Fey PD, Foreman MCL, Xu L, Penewit K, Waalkes A, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

Comprehensive pharmacokinetic/pharmacodynamic analysis of commercially available premixed daptomycin preparations against <i>Staphylococcus aureus</i> and <i>Enterococcus</i> spp. bloodstream infections using Monte Carlo simulation in adult patients. [PDF]

JAC Antimicrob Resist
Jaime E, Yassin A, Patel RH, Bhowmick T, Farkas A.   +4 more
europepmc   +1 more source

Bridging the Gap: Optimizing OPAT Transitions to Skilled Nursing Facilities. [PDF]

Open Forum Infect Dis
Mehta M, Tedeschi C, Zhang J, Morjaria S, Johnson J.   +4 more
europepmc   +1 more source

Adverse events leading to discontinuation of daptomycin versus vancomycin in outpatient parenteral antimicrobial therapy: a retrospective cohort study. [PDF]

JAC Antimicrob Resist
Lanier K, Jawanda J, Cid A.
europepmc   +1 more source

Biofilm structure as a key factor in antibiotic tolerance: insights from Bacillus subtilis model systems. [PDF]

NPJ Biofilms Microbiomes
Blaznik M, Volk M, Kraigher B, Calonge-Sanz A, Barco-García G, Stopar D, Dogsa I.   +6 more
europepmc   +1 more source

The last resort antibiotic daptomycin exhibits two independent antibacterial mechanisms of action. [PDF]

Nat Commun
Buttress JA, Schäfer AB, Koh A, Wheatley J, Mickiewicz K, Wenzel M, Strahl H.   +6 more
europepmc   +1 more source

Non-susceptibility of <i>Enterococcus faecalis</i> to daptomycin detected by VITEK-2 P639 card: clinical reporting is not recommended. [PDF]

Microbiol Spectr
Xing Y, Zhang J, Sun L, Li N, Wang H, Zhang Y, Jia X, Sun H.   +7 more
europepmc   +1 more source

A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system. [PDF]

Sci Rep
Ye L, Guo G, Zhou H, Chen M, Fan Z, Zhang J.   +5 more
europepmc   +1 more source

Risk factors of daptomycin overexposure: a case-control study. [PDF]

Antimicrob Agents Chemother
Vellat C, Garreau R, Millet A, Piron C, Bourguignon L, Roux S, Ferry T, Goutelle S, Lyon Bone and Joint Infection Study Group.   +8 more
europepmc   +1 more source

Daptomycin is associated with higher treatment failure rates than alternatives for Enterococcus faecium bloodstream infections in critically ill patients: a multicentric retrospective cohort. [PDF]

Crit Care
Herbel S, Dumas G, Chantelot L, Massol J, Nagle S, Lecronier M, Turpin M, Moyon Q, Ricard JD, Petit M, Azoulay E, Hauw-Berlemont C, Tankovic J, Joffre J, Ait-Oufella H, Maury E, Urbina T, ENTERODAPTO Study Group.   +17 more
europepmc   +1 more source